About this trial
Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, was found to be effective for increasing adolescent HPV vaccination in primary care, its dissemination is limited by the need for significant research team involvement to teach providers how to use the intervention's components. To address this, investigators propose to develop and test a virtual version of PCOM, use mixed methods to assess contextual factors affecting its use compared to the original PCOM intervention, and develop an optimized version of PCOM for broad dissemination to increase adolescent HPV vaccination nationally.
Eligibility criteria
Qualifiers
Parents: Have an adolescent between the ages of 9-17 years old and receiving adolescent care at an enrolled clinic
Providers: All providers at participating study practices will be eligible to participate.
Disqualifiers
Parents: Does not have an adolescent between the ages of 9-17 years old and is not receiving adolescent care at an enrolled clinic
Providers: Providers who are not at participating study practices
Trial design
Treatments tested in this trial
- Physician Communication 2 Virtual (PCOM2-virtual)
- Physician Communication Standard (PCOM-standard)
Treatment groups
Sponsors and collaborators
University of Colorado, Denver
Lead sponsor
University of Kansas Medical Center
Collaborator
San Diego State University
Collaborator